Parallax Volatility Advisers
EPZM

Parallax Volatility Advisers’s Epizyme, Inc EPZM Stock Holding History

Parallax Volatility Advisers’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,100
Closed -$62K – 4354
2018
Q4 		$62K Buy
+10,100
New +$77.1K ﹤0.01% 2060
2018
Q1 		– Sell
-7,476
Closed -$94K – 4755
2017
Q4 		$94K Buy
+7,476
New +$109K ﹤0.01% 2843

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Parallax Volatility Advisers's EPZM Position: Q1 2019 in Review

Parallax Volatility Advisers sold out of Epizyme, Inc (EPZM) in Q1 2019, closing a stake of 10,100 shares — an estimated $62K sold.

Parallax Volatility Advisers first reported a position in EPZM in Q4 2017 and held it in 2 quarters. The position peaked at $94K in Q4 2017. 121 funds tracked by Wall St. Rank hold EPZM as of Q1 2019.

  • Parallax Volatility Advisers reported no remaining Epizyme, Inc position as of Q1 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 10,100 Epizyme, Inc shares in Q1 2019, an estimated $62K.
  • Parallax Volatility Advisers first reported a position in Epizyme, Inc in Q4 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's Epizyme, Inc position peaked at $94K in Q4 2017.
  • 121 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2019.

Based on Parallax Volatility Advisers's 13F filing for Q1 2019, filed 15 May 2019.